Compare AHMA & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AHMA | CLNN |
|---|---|---|
| Founded | 2007 | 2012 |
| Country | United Arab Emirates | United States |
| Employees | 44 | 79 |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.6M | 79.1M |
| IPO Year | N/A | N/A |
| Metric | AHMA | CLNN |
|---|---|---|
| Price | $1.72 | $5.98 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $33.75 |
| AVG Volume (30 Days) | ★ 1.5M | 68.0K |
| Earning Date | 05-22-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $17.64 |
| Revenue Next Year | N/A | $19,516.77 |
| P/E Ratio | $180.72 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.76 | $3.25 |
| 52 Week High | $39.50 | $13.50 |
| Indicator | AHMA | CLNN |
|---|---|---|
| Relative Strength Index (RSI) | 46.28 | 48.56 |
| Support Level | $1.64 | $5.85 |
| Resistance Level | $1.82 | $6.63 |
| Average True Range (ATR) | 0.22 | 0.35 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 6.91 | 43.87 |
Ambitions Enterprise Management Co LLC, through its subsidiaries in the UAE, operates as a tour operator, travel agency, and event planning and management services provider. It provides two lines of services, namely, MICE management, a comprehensive coordination and organization of events, and one-stop tourism, a comprehensive travel product that is designed to provide tourists with all the necessary components of a trip in a single and convenient package, which typically include transportation, accommodations, meals, and guided tours or activities.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.